摘要 N-杂环卡宾(NHC)是由易获得的N-杂环咪唑盐以空气为末端氧化剂原位生成的,已成功地用作便宜且有效的一锅好氧氧化合成2-芳基苯并[ d ]恶唑的催化剂,2-取代的苯并[ d ]噻唑和1,2-二取代的苯并[ d ]咪唑。 N-杂环卡宾(NHC)是由易获得的N-杂环咪唑盐以空气为末端氧化剂原位生成的,已成功地用作便宜且有效的一锅好氧氧化合成2-芳基苯并[ d ]恶唑的催化剂,2-取代的苯并[ d ]噻唑和1,2-二取代的苯并[ d ]咪唑。
The present invention provides compounds of general Formula I and I′:
compositions thereof, and methods of using same to treat Rheb-mediated disorders.
本发明提供通式I和I′的化合物:
其组合物,以及用其治疗 Rheb 介导的疾病的方法。
HETEROARYL RHEB INHIBITORS AND USES THEREOF
申请人:Navitor Pharmaceuticals, Inc.
公开号:US20210238165A1
公开(公告)日:2021-08-05
The present invention provides compounds, compositions thereof, and methods of using the same. Compositions comprising a compound of this invention or a pharmaceutically acceptable derivative thereof and a pharmaceutically acceptable carrier, adjuvant, or vehicle. The amount of the compound in compositions of this invention is such that it is effective to measurably inhibit Rheb, in a biological sample or in a patient.